Global Cord Blood Corporation
Symbol: CO
NYSE
2.9876
USDMarket price today
5.2326
P/E Ratio
-0.0019
PEG Ratio
400.08M
MRK Cap
- 0.00%
DIV Yield
Global Cord Blood Corporation (CO) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 0 | 161.3 | 130.3 | 104.3 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 45.9 | 44.3 | 43.8 | ||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 11.9 | 47.8 | 44.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 6935 | 6298.1 | 5666.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 476.7 | 503.7 | 527.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 60.8 | 55.8 | 50.7 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 696.2 | 653.4 | 592.5 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1599.5 | 1608.2 | 1553.7 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.account-payables | 0 | 8.3 | 9.5 | 20 | ||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 1.6 | 1.7 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 31.2 | 29.5 | 32.3 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 1.8 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 2473.5 | 2392.9 | 2289.8 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 179.8 | 166 | 146.3 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 3003 | 2891.4 | 2760.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.total-liab | 0 | 3649.6 | 3517.9 | 3331.4 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 2887.3 | 2386.2 | 1877.9 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -106.8 | -103.2 | -94.7 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2098.8 | 2098.8 | 2098.8 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 4879.3 | 4381.9 | 3882.1 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 5.7 | 6.6 | 6.4 | ||||||||||||||||
balance-sheet.row.total-equity | 0 | 4885 | 4388.5 | 3888.5 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||
Total Investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.total-debt | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.net-debt | 0 | -6660.8 | -6074 | -5469.9 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 509.5 | 516.2 | 477.7 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 47.9 | 49.1 | 49.4 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 3.2 | -7.2 | -7.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 11.7 | 37.6 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -3.8 | 58.3 | 64.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | -102.9 | -120.4 | -86.9 | ||||||||||||||||
cash-flows.row.inventory | 0 | -5.3 | -6.8 | -24.1 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -1.1 | -10.5 | -13.6 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 105.7 | 196.1 | 188.6 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 56.7 | 2.6 | 2.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -340 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 210 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0.2 | 0.8 | 8.2 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -19.6 | -20.1 | -146.1 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -1.1 | -2.1 | 1.6 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 585.2 | 602.4 | 475.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 6075.8 | 5473.4 | 4997.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 613.6 | 630.7 | 624 | ||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 593.8 | 609.8 | 599.8 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1243.3 | 1159.6 | 1221.5 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 183.3 | 178.9 | 189.1 | ||||||||||||||||
income-statement-row.row.gross-profit | 0 | 1059.9 | 980.7 | 1032.3 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 451.1 | 435.8 | 473.3 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 634.4 | 614.8 | 662.4 | ||||||||||||||||
income-statement-row.row.interest-income | 0 | 32.6 | 30.9 | 25.4 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 19.9 | -26.8 | 13 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 0 | 608.9 | 544.9 | 559 | ||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 627.8 | 610.8 | 578.8 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 118.4 | 94.5 | 101.1 | ||||||||||||||||
income-statement-row.row.net-income | 0 | 501.1 | 508.2 | 470.7 |
Frequently Asked Question
What is Global Cord Blood Corporation (CO) total assets?
Global Cord Blood Corporation (CO) total assets is 8534525000.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.853.
What is company free cash flow?
The free cash flow is 4.885.
What is enterprise net profit margin?
The net profit margin is 0.403.
What is firm total revenue?
The total revenue is 0.490.
What is Global Cord Blood Corporation (CO) net profit (net income)?
The net profit (net income) is 501065000.000.
What is firm total debt?
The total debt is 147000.000.
What is operating expences number?
The operating expences are 451083000.000.
What is company cash figure?
Enretprise cash is 0.000.